Advertisement
New Zealand markets open in 6 hours 19 minutes
  • NZX 50

    11,800.78
    -20.00 (-0.17%)
     
  • NZD/USD

    0.6015
    +0.0003 (+0.05%)
     
  • ALL ORDS

    8,065.50
    +113.20 (+1.42%)
     
  • OIL

    78.31
    -0.17 (-0.22%)
     
  • GOLD

    2,323.80
    -7.40 (-0.32%)
     

FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?

FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?

The Federal Trade Commission (FTC) has been taking a much more adversarial approach to mergers and acquisitions lately. For instance, it recently said it plans to block the pending deal between pharmaceutical companies Horizon Therapeutics (NASDAQ: HZNP) and Amgen (NASDAQ: AMGN). Does the FTC's recent tough stance on big deals increase the chances that Pfizer's (NYSE: PFE) acquisition of Seagen (NASDAQ: SGEN) will also run into problems?